The signaling pathways activated by ROR1 in cancer

被引:16
作者
Quezada, Maria Josefina [1 ,2 ]
Lopez-Bergami, Pablo [1 ,2 ,3 ]
机构
[1] Univ Maimonides, Ctr Estudios Biomed Basicos Aplicados & Desarrollo, RA-1405 Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, RA-1425 Buenos Aires, DF, Argentina
[3] Univ Maimonides, Ctr Estudios Biomed Biotecnol Ambientales & Diagno, Hidalgo 775,6th Floor,Lab 602, RA-1425 Buenos Aires, DF, Argentina
关键词
ROR1; WNT5A; cancer; Tyrosine kinase; AKT; MAPK; NF-?B; STAT3; WNT5A INDUCES ROR1; TARGETING ROR1; MESENCHYMAL TRANSITION; LUNG ADENOCARCINOMA; STEM-CELLS; RECEPTOR; EXPRESSION; CHEMOTAXIS; MIGRATION; APOPTOSIS;
D O I
10.1016/j.cellsig.2023.110588
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The receptor tyrosine kinase orphan receptor 1 (ROR1) is a receptor for WNT5A and related Wnt proteins, that play an important role during embryonic development by regulating cell migration, cell polarity, neural patterning, and organogenesis. ROR1 exerts these functions by transducing signals from the Wnt secreted gly-coproteins to the intracellular Wnt/PCP and Wnt/Ca++ pathways. Investigations in adult human cells, particu-larly cancer cells, have demonstrated that besides these two pathways, the WNT5A/ROR1 axis can activate a number of signaling pathways, including the PI3K/AKT, MAPK, NF-Kappa B, STAT3, and Hippo pathways. Moreover, ROR1 is aberrantly expressed in cancer and was associated with tumor progression and poor survival by pro-moting cell proliferation, survival, invasion, epithelial to mesenchymal transition, and metastasis. Consequently, numerous therapeutic tools to target ROR1 are currently being evaluated in cancer patients. In this review, we will provide a detailed description of the signaling pathways regulated by ROR1 in cancer and their impact in tumor progression.
引用
收藏
页数:11
相关论文
共 104 条
  • [1] The Deleted in Brachydactyly B Domain of ROR2 Is Required for Receptor Activation by Recruitment of Src
    Akbarzadeh, Shiva
    Wheldon, Lee M.
    Sweet, Steve M. M.
    Talma, Sonia
    Mardakheh, Faraz Khosravi
    Heath, John K.
    [J]. PLOS ONE, 2008, 3 (03):
  • [2] Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
    Bainbridge, Travis W.
    DeAlmeida, Venita I.
    Izrael-Tomasevic, Anita
    Chalouni, Cecile
    Pan, Borlan
    Goldsmith, Joshua
    Schoen, Alia P.
    Quinones, Gabriel A.
    Kelly, Ryan
    Lill, Jennie R.
    Sandoval, Wendy
    Costa, Mike
    Polakis, Paul
    Arnott, David
    Rubinfeld, Bonnee
    Ernst, James A.
    [J]. PLOS ONE, 2014, 9 (07):
  • [3] Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues
    Balakrishnan, Ashwini
    Goodpaster, Tracy
    Randolph-Habecker, Julie
    Hoffstrom, Benjamin G.
    Jalikis, Florencia G.
    Koch, Lisa K.
    Berger, Carolina
    Kosasih, Paula L.
    Rajan, Anusha
    Sommermeyer, Daniel
    Porter, Peggy L.
    Riddell, Stanley R.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3061 - 3071
  • [4] An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma
    Barbero, Gaston
    Castro, Maria Victoria
    Villanueva, Maria Belen
    Quezada, Maria Josefina
    Fernandez, Natalia Brenda
    DeMorrow, Sharon
    Lopez-Bergami, Pablo
    [J]. CELLS, 2019, 8 (09)
  • [5] Regulation of Akt/PKB Ser473 phosphorylation
    Bayascas, JR
    Alessi, DR
    [J]. MOLECULAR CELL, 2005, 18 (02) : 143 - 145
  • [6] ROR1 Contributes to Melanoma Cell Growth and Migration by Regulating N-Cadherin Expression via the PI3K/Akt Pathway
    Brenda Fernandez, Natalia
    Lorenzo, Daniela
    Elisa Picco, Maria
    Barbero, Gaston
    Sebastian Dergan-Dylon, Leonardo
    Paula Marks, Maria
    Garcia-Rivello, Hernan
    Gimenez, Liliana
    Labovsky, Vivian
    Grumolato, Luca
    Lopez-Bergami, Pablo
    [J]. MOLECULAR CARCINOGENESIS, 2016, 55 (11) : 1772 - 1785
  • [7] Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1
    Cao, Jingying
    Wang, Xin
    Dai, Tao
    Wu, Yuanzhong
    Zhang, Meifang
    Cao, Renxian
    Zhang, Ruhua
    Wang, Gang
    Jiang, Rou
    Zhou, Binhua P.
    Shi, Jian
    Kang, Tiebang
    [J]. THERANOSTICS, 2018, 8 (10): : 2739 - 2751
  • [8] Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma
    Chang, Hyeyoon
    Jung, Woon Yong
    Kang, Youngran
    Lee, Hyunjoo
    Kim, Aeree
    Kim, Baek-hui
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2015, 19 (05) : 330 - 334
  • [9] Wnt5a Induces Association of ROR1 with Ca2+/Calmodulin-Dependent Protein Kinase II and ROR1-Dependent Calcium Influx in Chronic Lymphocytic Leukemia
    Chen, Liguang
    Chen, Yun
    Yu, Jian
    Zhang, Ling
    Rassenti, Laura Z.
    Kipps, Thomas J.
    [J]. BLOOD, 2018, 132
  • [10] Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia
    Chen, Yun
    Chen, Liguang
    Yu, Jian
    Ghia, Emanuela M.
    Choi, Michael Y.
    Zhang, Ling
    Zhang, Suping
    Sanchez-Lopez, Elsa
    Widhopf, George F., II
    Messer, Karen
    Rassenti, Laura Z.
    Jamieson, Catriona
    Kipps, Thomas J.
    [J]. BLOOD, 2019, 134 (13) : 1084 - 1094